| P50 | author | Daniel Portalez | Q60660272 |
| P2093 | author name string | H Marret | |
| | J-M Correas | |
| | F Tranquart | |
| | A Bleuzen | |
| P2860 | cites work | Management of hepatocellular carcinoma | Q29616230 |
| | Molecular imaging with contrast ultrasound and targeted microbubbles | Q30312262 |
| | Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications | Q30439569 |
| | Ultrasound assessment of angiogenesis in a matrigel model in rats | Q30503581 |
| | The role of contrast-enhanced ultrasound in the detection of focal liver leasions. | Q34495408 |
| | The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions | Q34495414 |
| | Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer | Q36672539 |
| | Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score | Q39800506 |
| | Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography | Q40127766 |
| | Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature | Q40187867 |
| | Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. | Q40263635 |
| | Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography | Q40276910 |
| | Therapeutic effects of paclitaxel-containing ultrasound contrast agents | Q45306316 |
| | Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model | Q46486160 |
| | Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats | Q46489393 |
| | Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma | Q46513814 |
| | Assessment of microvascular perfusion changes in a rat breast tumor model using SonoVue to monitor the effects of different anti-angiogenic therapies | Q46655630 |
| | Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results | Q46851565 |
| | Enhancing effects of SonoVue, a microbubble sonographic contrast agent, on high-intensity focused ultrasound ablation in rabbit livers in vivo | Q50249284 |
| | Contrast-enhanced sonographic imaging of lymphatic channels and sentinel lymph nodes. | Q50484207 |
| | Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging. | Q51240087 |
| | Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization. | Q51782199 |
| | Relationship of skeletal muscle perfusion measured by contrast-enhanced ultrasonography to histologic microvascular density. | Q51943234 |
| | Detecting vascular changes in tumour xenografts using micro-ultrasound and micro-ct following treatment with VEGFR-2 blocking antibodies. | Q53484548 |
| | Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. | Q53541526 |
| | Assessment of the therapeutic response of hepatocellular carcinoma treated with transcatheter arterial chemoembolization: comparison of contrast-enhanced sonography and 3-phase computed tomography. | Q53545241 |
| | Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. | Q53579816 |
| | Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. | Q53603316 |
| | Complex cystic renal masses: characterization with contrast-enhanced US | Q56786305 |
| | Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial results | Q63719414 |
| | Comparison of B-Mode and Conventional Colour/Power Doppler Ultrasound, Contrast-Enhanced Doppler Ultrasound and Spiral CT in the Diagnosis of Focal Lesions of the Liver: Results of a Multicentre Study | Q64025820 |
| | Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions | Q77677750 |
| | To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound | Q80242426 |
| | American Institute ofUltrasound in Medicine recommendations for contrast-enhanced liver ultrasound imaging clinical trials | Q80384926 |
| | Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue | Q81119638 |
| | Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? | Q82350270 |
| P433 | issue | 11 Pt 2 | |
| P921 | main subject | contrast-enhanced ultrasound | Q500458 |
| P304 | page(s) | 1759-1769 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Journal de radiologie | Q27711733 |
| P1476 | title | [Recent advances in contrast-enhanced ultrasound for oncology applications] | |
| P478 | volume | 88 | |